BC is a highly heterogeneous disease, categorized into three groups based on different molecular profiles: luminal A/B (ER/PgR+, HER2- or +), HER2+ (ER/PgR-, HER2+) and triple negative (or basal-like, ER/PgR/HER2-) [3]. Here, PGR is linked to breast cancer.